QuantX: First FDA-Approved AI System for Breast Cancer Diagnosis, Reducing Missed Diagnoses by 39%

This article is reprinted from: ifanr

Breast cancer has become the leading malignant tumor seriously threatening women's health. Relevant surveys show that, as of 2015, more than 560,000 people worldwide had died from breast cancer.

Today, an AI-based breast cancer diagnosis system, QuantX, was proven in clinical trials to effectively assist physicians in diagnosing breast cancer. In these trials, QuantX was used to help radiologists interpret MRI scans and differentiate between breast cancer and non-cancerous breast lesions. The results demonstrated that the use of this artificial intelligence diagnostic system increased overall diagnostic efficiency by 20% and reduced the missed diagnosis rate by 39%.

Relevant information indicates that QuantX was initially developed by the University of Chicago and later acquired by Qlarity, a company focused on developing AI-powered healthcare systems.

(Image source: FastCompany)）

In addition to helping physicians improve efficiency, the system also reduces the duration and pain experienced by women during the diagnostic process.

Meghan Harrison, Chief Operating Officer of Qlarity Imaging, stated that approximately 30 million women in the United States undergo breast cancer screening each year. During this process, they must endure not only physical discomfort, such as from biopsies, but also psychological anxiety associated with waiting for surgical scheduling.

The advent of QuantX not only alleviates physical discomfort during the examination phase but also significantly shortens the waiting time for results, thereby reducing psychological distress.

Image source: MIT News

It is understood that QuantX is not the first diagnostic platform to apply AI to breast cancer screening.

As early as 2016, Beth Israel Deaconess Medical Center in Israel and Harvard Medical School collaborated to develop an artificial intelligence project designed to assist physicians in rapidly reading and identifying cancer cells in pathological images, with breast cancer being the first target condition addressed by the initiative.

Furthermore, last year, an internet user named coolwulf single-handedly built an artificial intelligence system capable of assisting in the diagnosis of breast cancer, using 50 Nvidia GeForce GTX 1080 Ti graphics cards, achieving an accuracy rate as high as 90%.

Image from: coolwulf

Compared with other diagnostic platforms, QuantX is the first AI-powered breast cancer diagnosis system approved by the U.S. Food and Drug Administration (FDA). Following FDA approval, QuantX is also poised to officially begin providing services at the Department of Radiology of The University of Texas MD Anderson Cancer Center and the University of Chicago.

Background image source: Forbes

Source: https://www.ifanr.com/1238448